RAD51C mutations c.93delG and c.837+1G>A were observed at a combined frequency of 1.0% among unselected ovarian cancer patients and at 2.1% frequency among breast and ovarian cancer families and associated with an increased risk of ovarian cancer [18]. The gene discussed is RAD51C; the disease is ovarian cancer.